- Home
- ANIP vs LX Comparison
ANIP vs LX Comparison
Compare ANIP & LX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- LX
- Stock Information
- Founded
- ANIP 2001
- LX 2013
- Country
- ANIP United States
- LX China
- Employees
- ANIP N/A
- LX N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- LX Finance: Consumer Services
- Sector
- ANIP Health Care
- LX Finance
- Exchange
- ANIP Nasdaq
- LX Nasdaq
- Market Cap
- ANIP 1.4B
- LX 1.3B
- IPO Year
- ANIP N/A
- LX 2017
- Fundamental
- Price
- ANIP $65.31
- LX $6.96
- Analyst Decision
- ANIP Strong Buy
- LX
- Analyst Count
- ANIP 8
- LX 0
- Target Price
- ANIP $80.13
- LX N/A
- AVG Volume (30 Days)
- ANIP 253.3K
- LX 2.3M
- Earning Date
- ANIP 08-05-2025
- LX 08-26-2025
- Dividend Yield
- ANIP N/A
- LX 2.61%
- EPS Growth
- ANIP N/A
- LX 35.86
- EPS
- ANIP N/A
- LX 1.07
- Revenue
- ANIP $674,068,000.00
- LX $1,938,367,396.00
- Revenue This Year
- ANIP $30.52
- LX $2.38
- Revenue Next Year
- ANIP $7.40
- LX $8.71
- P/E Ratio
- ANIP N/A
- LX $7.08
- Revenue Growth
- ANIP 30.27
- LX 5.63
- 52 Week Low
- ANIP $52.50
- LX $1.57
- 52 Week High
- ANIP $77.00
- LX $11.64
- Technical
- Relative Strength Index (RSI)
- ANIP 55.12
- LX 42.44
- Support Level
- ANIP $63.17
- LX $6.92
- Resistance Level
- ANIP $66.18
- LX $7.79
- Average True Range (ATR)
- ANIP 1.83
- LX 0.33
- MACD
- ANIP 0.00
- LX 0.03
- Stochastic Oscillator
- ANIP 54.23
- LX 17.82
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About LX LexinFintech Holdings Ltd.
LexinFintech Holdings Ltd is an online consumer finance platform and a technology-driven service provider in China. The group is engaged in online direct sales services and online consumer finance services for its customers in the PRC. Geographically, it derives revenue from China.